Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on April 25, 2005

Circulation. 2005
Published online before print April 25, 2005, doi: 10.1161/01.CIR.0000164201.40634.1D
A more recent version of this article appeared on May 10, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/18/2364    most recent
01.CIR.0000164201.40634.1Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Csiszar, A.
Right arrow Articles by Ungvari, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Csiszar, A.
Right arrow Articles by Ungvari, Z.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROGEN PEROXIDE
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Growth factors/cytokines
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors

Submitted on July 29, 2004
Revised on December 20, 2004
Accepted on December 21, 2004

Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells. Role of Nuclear Factor-{kappa}B Activation by Tumor Necrosis Factor-{alpha}, H2O2, and High Intravascular Pressure

Anna Csiszar MD, PhD, Kira E. Smith , Akos Koller MD, PhD, Gabor Kaley PhD, John G. Edwards PhD, and Zoltan Ungvari MD, PhD*

From the Department of Physiology, New York Medical College, Valhalla, NY.

* To whom correspondence should be addressed. E-mail: zoltan_ungvari{at}nymc.edu.

Background--Recent studies suggest that bone morphogenetic protein-2 (BMP-2), a transforming growth factor-{beta} superfamily member cytokine, plays an important role both in vascular development and pathophysiological processes, including endothelial activation that is likely to contribute to the development of coronary atherosclerosis, yet the factors that regulate arterial expression of BMP-2 are completely unknown. We tested the hypothesis that BMP-2 expression in endothelial cells is governed by an H2O2 and nuclear factor (NF)-{kappa}B-dependent pathway that can be activated by both proinflammatory and mechanical stimuli.

Methods and Results--The proinflammatory cytokine tumor necrosis factor (TNF)-{alpha} induced NF-{kappa}B activation and elicited significant increases in BMP-2 mRNA and protein in primary coronary arterial endothelial cells and human umbilical vein endothelial cells that were prevented by NF-{kappa}B inhibitors (pyrrolidine dithiocarbamate and SN-50), silencing of p65 (siRNA), or catalase. Administration of H2O2 also elicited NF-{kappa}B activation and BMP-2 induction. In organ culture, exposure of rat arteries to high pressure (160 mm Hg) elicited H2O2 production, nuclear translocation of NF-{kappa}B, and upregulation of BMP-2 expression. Although high pressure upregulated TNF-{alpha}, it appears that it directly regulates BMP-2 expression, because upregulation of BMP-2 was also observed in vessels of TNF-{alpha} knockout mice.

Conclusions--Vascular BMP-2 expression can be regulated by H2O2-mediated activation of NF-{kappa}B both by inflammatory stimuli and by high intravascular pressure.


Key words: free radicals • cytokines • growth factors




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari
Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B
J Appl Physiol, October 1, 2008; 105(4): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ungvari, N. Labinskyy, S. Gupte, P. N. Chander, J. G. Edwards, and A. Csiszar
Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2121 - H2128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Meng, L. Ao, Y. Song, A. Babu, X. Yang, M. Wang, M. J. Weyant, C. A. Dinarello, J. C. Cleveland Jr., and D. A. Fullerton
Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C29 - C35.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Al-Aly, J.-S. Shao, C.-F. Lai, E. Huang, J. Cai, A. Behrmann, S.-L. Cheng, and D. A. Towler
Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-{alpha} Dependent Signals in Diabetic Ldlr / Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2589 - 2596.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. I. Ungvari
Endothelium-Derived Bone Morphogenic Protein Antagonists May Counteract the Proatherogenic Vascular Effects of Bone Morphogenic Protein 4
Circulation, September 11, 2007; 116(11): 1221 - 1223.
[Full Text] [PDF]


Home page
CirculationHome page
K. Chang, D. Weiss, J. Suo, J. D. Vega, D. Giddens, W. R. Taylor, and H. Jo
Bone Morphogenic Protein Antagonists Are Coexpressed With Bone Morphogenic Protein 4 in Endothelial Cells Exposed to Unstable Flow In Vitro in Mouse Aortas and in Human Coronary Arteries: Role of Bone Morphogenic Protein Antagonists in Inflammation and Atherosclerosis
Circulation, September 11, 2007; 116(11): 1258 - 1266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ungvari, Z. Orosz, N. Labinskyy, A. Rivera, Z. Xiangmin, K. Smith, and A. Csiszar
Increased mitochondrial H2O2 production promotes endothelial NF-{kappa}B activation in aged rat arteries
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H37 - H47.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Csiszar, N. Labinskyy, K. E. Smith, A. Rivera, E. N.T.P. Bakker, H. Jo, J. Gardner, Z. Orosz, and Z. Ungvari
Downregulation of Bone Morphogenetic Protein 4 Expression in Coronary Arterial Endothelial Cells: Role of Shear Stress and the cAMP/Protein Kinase A Pathway
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Nitenberg
Macrovascular disease in type 2 diabetes: We do need animal models for in vivo studies
Cardiovasc Res, February 1, 2007; 73(3): 450 - 452.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Bouvet, W. Peeters, S. Moreau, D. deBlois, and P. Moreau
A new rat model of diabetic macrovascular complication
Cardiovasc Res, February 1, 2007; 73(3): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Csiszar, N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari
Vasculoprotective Effects of Anti-Tumor Necrosis Factor-{alpha} Treatment in Aging
Am. J. Pathol., January 1, 2007; 170(1): 388 - 698.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. X. Chen, D. Duan, K. D. O'Neill, and S. M. Moe
High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3435 - 3442.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Csiszar, K. Smith, N. Labinskyy, Z. Orosz, A. Rivera, and Z. Ungvari
Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1694 - H1699.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. Faraci
Hydrogen peroxide: watery fuel for change in vascular biology.
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1931 - 1933.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. A. Lemarie, P.-L. Tharaux, B. Esposito, A. Tedgui, and S. Lehoux
Transforming Growth Factor-{alpha} Mediates Nuclear Factor {kappa}B Activation in Strained Arteries
Circ. Res., August 18, 2006; 99(4): 434 - 441.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Lehoux
Redox signalling in vascular responses to shear and stretch
Cardiovasc Res, July 15, 2006; 71(2): 269 - 279.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-S. Shao, J. Cai, and D. A. Towler
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1423 - 1430.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Miriyala, M. C. Gongora Nieto, C. Mingone, D. Smith, S. Dikalov, D. G. Harrison, and H. Jo
Bone Morphogenic Protein-4 Induces Hypertension in Mice: Role of Noggin, Vascular NADPH Oxidases, and Impaired Vasorelaxation
Circulation, June 20, 2006; 113(24): 2818 - 2825.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. D. Michelakis
Spatio-Temporal Diversity of Apoptosis Within the Vascular Wall in Pulmonary Arterial Hypertension: Heterogeneous BMP Signaling May Have Therapeutic Implications
Circ. Res., February 3, 2006; 98(2): 172 - 175.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Csiszar, M. Ahmad, K. E. Smith, N. Labinskyy, Q. Gao, G. Kaley, J. G. Edwards, M. S. Wolin, and Z. Ungvari
Bone Morphogenetic Protein-2 Induces Proinflammatory Endothelial Phenotype
Am. J. Pathol., February 1, 2006; 168(2): 629 - 638.
[Abstract] [Full Text] [PDF]